Exact Mass: 507.1839
Exact Mass Matches: 507.1839
Found 108 metabolites which its exact mass value is equals to given mass value 507.1839
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2E)-3-[2,3-dihydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-1,4-benzodioxin-6-yl]-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide|thoreliamide B
Ala Cys Glu Trp
Ala Cys Trp Glu
Ala Glu Cys Trp
Ala Glu Trp Cys
Ala Trp Cys Glu
Ala Trp Glu Cys
Cys Ala Glu Trp
Cys Ala Trp Glu
Cys Asp Asp Arg
Cys Asp Arg Asp
Cys Glu Ala Trp
Cys Glu Trp Ala
Cys Arg Asp Asp
Cys Trp Ala Glu
Cys Trp Glu Ala
Asp Cys Asp Arg
Asp Cys Arg Asp
Asp Asp Cys Arg
Asp Asp Arg Cys
Asp Gly Met Trp
Asp Gly Trp Met
Asp Met Gly Trp
Asp Met Trp Gly
Asp Arg Cys Asp
Asp Arg Asp Cys
Asp Trp Gly Met
Asp Trp Met Gly
Glu Ala Cys Trp
Glu Ala Trp Cys
Glu Cys Ala Trp
Glu Cys Trp Ala
Glu Trp Ala Cys
Glu Trp Cys Ala
Gly Asp Met Trp
Gly Asp Trp Met
Gly Met Asp Trp
Gly Met Trp Asp
Gly Trp Asp Met
Gly Trp Met Asp
b-D-Glucopyranosiduronic acid, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxyphenyl, (3S-tr
5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol glucuronide
Met Asp Gly Trp
Met Asp Trp Gly
Met Gly Asp Trp
Met Gly Trp Asp
Met Trp Asp Gly
Met Trp Gly Asp
Arg Cys Asp Asp
Arg Asp Cys Asp
Arg Asp Asp Cys
Trp Ala Cys Glu
Trp Ala Glu Cys
Trp Cys Ala Glu
Trp Cys Glu Ala
Trp Asp Gly Met
Trp Asp Met Gly
Trp Glu Ala Cys
Trp Glu Cys Ala
Trp Gly Asp Met
Trp Gly Met Asp
Trp Met Asp Gly
Trp Met Gly Asp
(S,E)-ETHYL 7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-5-HYDROXY-3-OXOHEPT-6-ENOATE
2-[(1E,3Z)-3-CYANO-5-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
CLEBOPRIDE malATE
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clebopride malate is a dopamine antagonist used in the study of functional gastrointestinal disorders.
1,3,5-tris[3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzene
Umeclidinium Bromide
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.
(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-thiazolylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
Ibiglustat (succinate)
Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].
n-[(2r,3r,4r,6r)-6-{[(3s)-3-ethyl-6-hydroxy-1,7,12-trioxo-3,4-dihydro-2h-tetraphen-8-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]ethanimidic acid
(12r,15s)-9-ethyl-4,18-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[18.3.1.0⁵,²³.0¹⁵,²¹]tetracosa-1(23),2,4,10,16,18,20-heptaene-6,14,22,24-tetrone
3'-hydroxy-n-demethylrocaglamide
{"Ingredient_id": "HBIN008730","Ingredient_name": "3'-hydroxy-n-demethylrocaglamide","Alias": "NA","Ingredient_formula": "C28H29NO8","Ingredient_Smile": "CNC(=O)C1C(C2(C(C1O)(C3=C(C=C(C=C3O2)OC)OC)O)C4=CC(=C(C=C4)OC)O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9980","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}